Generic inhalation device developer Merxin has announced the launch of its MRX002 clear PET pMDI can, which allows developers to observe and model formulations in laboratory settings. According to the company, the cans are compatible with HFA, ethanol, PEG, and glycerol, and will work with commercially available valves.
Merxin, which was launched in December 2015 by inhalation experts Philippe Rogueda and Graham Purkins, is also offering “off the shelf” dry powder inhalers for generic inhalation products.
Read the Merxin announcement (requires LinkedIn access)
